|
Mechanismfungal CYP51A1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date11 Apr 2005 |
100 Clinical Results associated with Janus Pharmaceuticals, Inc.
0 Patents (Medical) associated with Janus Pharmaceuticals, Inc.
100 Deals associated with Janus Pharmaceuticals, Inc.
100 Translational Medicine associated with Janus Pharmaceuticals, Inc.